Pacific Island region on track to meet TB MDG, drug-resistance remains a threat

Experts at the Fifth Pacific Stop Tuberculosis Meeting in Nadi, Fiji, concluded that the Pacific Islands region is on track to meet the Millennium Development Goal of halving TB prevalence by 2015, All Headline News reports in an article about the meeting, which recently concluded.

Regional specialists noted that "the emergence of drug-resistant strains and concentrations of the disease in some areas makes it a continuing threat and a high priority for countries and territories," according to the news service (Tudrau-Tamani, 5/11). A press release from the Secretariat of the Pacific Community (SPC) states that there are about 18,000 reported cases of TB in the region each year. The area's 190 cases per 100,000 people is "2.5 times higher than that of the wider WHO Western Pacific region," which records 76 cases per 100,000 people (5/12).

The meeting "brought together 85 participants from national TB programs in 19 Pacific Island countries and territories," All Headline News writes. Technical experts from the SPC, the WHO, CDC, the International Union Against Tuberculosis and Lung Disease and the Global Fund to Fight AIDS, Tuberculosis and Malaria participated in the meeting (5/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CD4 T cells found to be key players in tuberculosis defense